Infective endocarditis resulting from CardioSEAL closure of a patent foramen ovale.
Patent foramen ovale and atrial septal aneurysm are associated with an increased risk of cryptogenic stroke and recurrent thromboembolic events. Percutaneous closure is a therapeutic option to medical therapy and surgical closure. We present the first case of endocarditis associated with a CardioSEAL device closing a patent foramen ovale.
Goldstein
Jeffrey A
JA
Division of Cardiovascular Medicine, Barnes-Jewish Hospital, Washington University School of Medicine, 660 South Euclid Ave., Saint Louis, MO 63110, USA. jgoldste@im.wustl.edu
Beardslee
Michael A
MA
Xu
Haodong
H
Sundt
Thoralf M
TM
Lasala
John M
JM
D000328:Adult; D006348:Cardiac Surgical Procedures / Q000009:adverse effects / Q000295:instrumentation; D004696:Endocarditis / Q000209:etiology*; D004868:Equipment Failure; D006344:Heart Septal Defects, Atrial / Q000150:complications* / Q000601:surgery*; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000209:etiology